HIMS – hims & hers health, inc. class a (US:NASDAQ)

News

Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Hims & Hers Continues Major International Expansion With Official Entry Into Canada [Yahoo! Finance]
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity [Seeking Alpha]
Humana And Mark Cuban's Cost Plus Drugs Working On Partnership To Lower Prices [Forbes]
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com